NCT04056026View on ClinicalTrials.gov

A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

September 18, 2018

Primary Completion Date

December 18, 2018

Study Completion Date

December 18, 2018

Conditions

Mesothelioma

Interventions

BIOLOGICAL

Fecal Microbiota Transplant

Fecal material from a healthy family donor will be transplanted into the patient via colonoscopy

Trial Locations (1)

93003

ProgenaBiome, Ventura

Sponsors

Lead Sponsor

All Listed Sponsors

lead

ProgenaBiome

OTHER

NCT04056026 - A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma | Biotech Hunter | Biotech Hunter